Last reviewed · How we verify
NCT05268029
Making HD Voices Heard
trial in Huntington Disease in 698 participants. Completed in 11 October 2023.
11 October 2023
Quick facts
| Lead sponsor | Huntington Study Group |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 698 |
| Start date | 23 March 2022 |
| Primary completion | 11 October 2023 |
| Estimated completion | 11 October 2023 |
| Sites | 1 location across United States |
Conditions studied
- Huntington Disease — all drugs for Huntington Disease →
Sponsor
Huntington Study Group
Who can join
18 and older, any sex, with Huntington Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Pilot Study, Making HD Voices Heard, will ask people living with HD to report what they experience and how they function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05268029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Huntington Disease
Currently open trials in the same condition.
- NCT07326709 — A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease · Phase 3 · recruiting
- NCT07253038 — Evaluation of Three Tests to Assess Social Cognition in Huntington Disease · recruiting
- NCT06774443 — Hinting Task for Huntington's Disease · recruiting
- NCT06546488 — Cognitive Assessment Tools for Huntington's Disease. · recruiting
- NCT07010705 — Digital Measures for Clinical Trial Endpoints in Huntington's Disease · recruiting
Other Huntington Study Group trials
Trials by the same sponsor.
- NCT06343220 — Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research · completed
- NCT05748288 — Development of the Virtual Unified Huntington's Disease Rating Scale · completed
- NCT00052143 — Prospective Huntington At Risk Observational Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05268029 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Huntington Study Group
- Last refreshed: 12 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05268029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing